Objectives

Translational biomedicine is the process of turning appropriate biological discoveries into drugs and medical devices that can be used in the treatment of patients. This field is rapidly progressing along with the advance in cutting-edge laboratory technologies used for the study of DNA, RNA and proteins. The most recent example has been the advent of next generation sequencing that is permitting to characterize the genetic material of different species at the genomic, transcriptomic and epigenomic levels. However, the translation of current knowledge to improve patient care still remains a formidable challenge. This workshop aims at providing a dedicated forum for the application of translational genomics in biomedicine nowadays. It will offer examples of the application of this discipline in several human diseases including cancer, diabetes, hepatitis and rare diseases. The ultimate goal of the presented research will be the optimization of patient healthcare and preventive measures.

Organizers

  • Sergi Castellví-Bel (IDIBAPS, Spain)
  • Cristina Fillat (IDIBAPS, Spain)
  • Meritxell Gironella (CIBEREHD, Spain)
  • Thomas Ried (National Cancer Institute, USA)
  • Lluís Hernández (IDIBAPS, Spain)
  • Sílvia Beà (IDIBAPS, Spain)

Confirmed Speakers

  • Beatriz Carvalho (VU University Medical Center, Netherlands)
  • Sílvia Beà (IDIBAPS, Spain)
  • Rameen Beroukhim (Dana-Farber Cancer Institute, USA)
  • Trine Nielsen (The Novo Nordisk Foundation Center for Basic Metabolic Research, Denmark)
  • Patricia Lepage (MICALIS-INRA, France)
  • Xin W. Wang (National Cancer Institute, USA)
  • Muneesh Tewari (Fred Hutchinson Cancer Research Center, USA)
  • Anne-Lise Børresen-Dale (Oslo University Hospital, Norway)
  • Jonel Trebicka (University of Bonn, Germany)
  • Alexandra Martins (University of Rouen, France)
  • Stephan Beck (University College London, UK)
  • Peter Laird (SC Norris Comprehensive Cancer Center, USA)
  • Antònia Ribes (Hospital Clínic de Barcelona, Spain)
  • Richard Houlston (Institute of Cancer Research, UK)
  • Xavier Estivill (Centre de Regulació Genòmica, Spain)
  • Anne Galy (Généthon, France)
  • Carlos López-Otín (Universidad de Oviedo, Spain)